EAVE II
EAVE II logo

Uptake, effectiveness and safety of COVID-19 vaccines in children and young people in Scotland: Protocol for early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II)

Protocol for a prospective study to investigate the uptake, effectiveness and safety of COVID-19 vaccines in children and young people (CYP) aged 0 to 17 years in Scotland.

Uptake, effectiveness and safety of COVID-19 vaccines in children and young people in Scotland: Protocol for early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II)

Adeloye D, Katikireddi SV, Woolford L, et al.

Journal of Gloabl Health (2021). doi:  https://doi.org/10.7189/jogh.11.05026

DaC-VaP-2

This work is being done as part of the EAVE II associated project: The impact of COVID-19 vaccines in pregnancy, children and young people, and vulnerable groups (DaC-VaP-2).

Visit the Dac-Vap-2 study page for more information.

DaC-VaP-2 study page

Note

Below are the details of two editorial articles written by our researchers discussing the COVID-19 pandemic in children and young people.